Recombinant multi-species SLC37A4 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine SLC37A4 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene regulates glucose-6-phosphate transport from the cytoplasm to the lumen of the endoplasmic reticulum, in order to maintain glucose homeostasis. It also plays a role in ATP-mediated calcium sequestration in the lumen of the endoplasmic reticulum. Mutations in this gene have been associated with various forms of glycogen storage disease. Alternative splicing in this gene results in multiple transcript variants.[provided by RefSeq, Aug 2009]
The Alternative Names of target: 100043178,CDG2W,G6PT,G6PT1,G6PT2,G6PT3,G6pt1,GSD-1b,GSD1b,GSD1c,GSD1d,Glucose-5-phosphate transporter,Glucose-6-phosphate exchanger SLC37A4,Glucose-6-phosphate translocase,PRO0685,SLC37A4,SPX4,Slc37a4,Solute carrier family 37 member 4,TRG-19,TRG19,Transformation-related gene 19 protein (TRG-19),mG6PT

Target products collectionGo to SLC37A4 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP0139-Ag-1/ GM-Tg-hg-IP0139-Ag-2 Human SLC37A4 protein Human
GM-Tg-rg-IP0139-Ag-1/ GM-Tg-rg-IP0139-Ag-2 Rat SLC37A4 protein Rat
GM-Tg-mg-IP0139-Ag-1/ GM-Tg-mg-IP0139-Ag-2 Mouse SLC37A4 protein Mouse
GM-Tg-cynog-IP0139-Ag-1/ GM-Tg-cynog-IP0139-Ag-2 Cynomolgus/Rhesus macaque SLC37A4 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP0139-Ag-1/ GM-Tg-felg-IP0139-Ag-2 Feline SLC37A4 protein Feline
GM-Tg-cang-IP0139-Ag-1/ GM-Tg-cang-IP0139-Ag-2 Canine SLC37A4 protein Canine
GM-Tg-bovg-IP0139-Ag-1/ GM-Tg-bovg-IP0139-Ag-2 Bovine SLC37A4 protein Bovine
GM-Tg-equg-IP0139-Ag-1/ GM-Tg-equg-IP0139-Ag-2 Equine SLC37A4 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP0139-Ag-1/ GM-Tg-hg-IP0139-Ag-2; GM-Tg-rg-IP0139-Ag-1/ GM-Tg-rg-IP0139-Ag-2;
GM-Tg-mg-IP0139-Ag-1/ GM-Tg-mg-IP0139-Ag-2; GM-Tg-cynog-IP0139-Ag-1/ GM-Tg-cynog-IP0139-Ag-2;
GM-Tg-felg-IP0139-Ag-1/ GM-Tg-felg-IP0139-Ag-2; GM-Tg-cang-IP0139-Ag-1/ GM-Tg-cang-IP0139-Ag-2;
GM-Tg-bovg-IP0139-Ag-1/ GM-Tg-bovg-IP0139-Ag-2; GM-Tg-equg-IP0139-Ag-1/ GM-Tg-equg-IP0139-Ag-2
Products Name SLC37A4 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name SLC37A4
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine SLC37A4 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.